Algorithmiq Company

Algorithmiq develops algorithms to solve currently inaccessible problems in life sciences. The company utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.

Stock Symbol:
Founders: Boris Sokolov,Guillermo Garcia-Perez,Matteo Rossi,Sabrina Maniscalco

Technologies: Algorithmiq, a Helsinki-based quantum algorithm company, develops advanced software solutions focused on quantum chemistry and life sciences, integrating quantum computing with AI and supercomputing. Key technologies include: Informationally Complete Measurement Data, Tensor Network Error Mitigation (TEM), Digital Quantum Interface (DQI), Error-Aware Quantum Algorithms, Aurora Platform (a quantum software platform for molecular simulations, enabling rapid data extraction from quantum computers), Hardware-Adapted Fermion-to-Qubit Mapping, Quantum Algorithms for Drug Discovery, development of fault-tolerant quantum chemistry workflows with Microsoft Quantum.


Connections from

Super Industry: Quantum Technology
Industry: Quantum Computing for Healthcare and Drug Discovery
Funding Status: private
Estimated Revenue: $1M to $10M
Headquarters: Turku,Western Finland,Finland,Europe
Founded Date: 2020
Employee Number: 11-50